يعرض 1 - 10 نتائج من 67 نتيجة بحث عن '"Libuse Tauchmanovà"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells

    المؤلفون: Francesco Orio, Giovanna Muscogiuri, Stefano Palomba, Bianca Serio, Mariarosaria Sessa, Valentina Giudice, Idalucia Ferrara, Libuse Tauchmanovà, Annamaria Colao, Carmine Selleri

    المصدر: The Scientific World Journal, Vol 2014 (2014)

    مصطلحات موضوعية: Technology, Medicine, Science

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/2356-6140; https://doaj.org/toc/1537-744X

    URL الوصول: https://doaj.org/article/328e9c778dbd49598497e471e7f64787

    View record at Wiley Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    Pharmacokinetics of osilodrostat following single and multiple doses of osilodrostat in healthy subjects and patients with Cushing's disease

    المؤلفون: Susan Atkinson, Xinrui Zhang, Kevin Han, Libuse Tauchmanovà, Francois Pierre Combes, Alberto M Pedroncelli, Christelle Darstein

    المصدر: Endocrine Abstracts.

    مصطلحات موضوعية: medicine.medical_specialty, Pharmacokinetics, business.industry, Internal medicine, medicine, Healthy subjects, Cushing's disease, medicine.disease, Multiple dosing, business, Gastroenterology, Osilodrostat

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1a5776dda3061e631be4ae7ad5dfcee4
    https://doi.org/10.1530/endoabs.63.gp162

    أضف إلى المفضلة
  3. 3
    A first-in-human pharmacokinetic, safety, and tolerability study of pasireotide subcutaneous depot

    المؤلفون: Susanne Glantz, Astrid Breitschaft, Libuse Tauchmanovà, Kerstin Strandgarden, Christelle Darstein, Fredrik Tiberg, Johannes Eisinger

    المصدر: Endocrine Abstracts.

    مصطلحات موضوعية: chemistry.chemical_compound, chemistry, Pharmacokinetics, business.industry, Depot, Tolerability Study, Medicine, First in human, Pharmacology, business, Pasireotide

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::50a387aef313378e8510ecdf7cbdec10
    https://doi.org/10.1530/endoabs.56.p856

    أضف إلى المفضلة
  4. 4
    Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing's disease: A Phase III extension study

    المؤلفون: Libuse Tauchmanovà, Pinar Kadioglu, Maria Fleseriu, Guy T'Sjoen, Marie C Vantyghem, John Newell-Price, S. Petersenn, Beverly M. K. Biller, Block Christophe De, André Lacroix, Shoba Ravichandran, Michael Roughton

    المصدر: Endocrine Abstracts.

    مصطلحات موضوعية: chemistry.chemical_compound, Pediatrics, medicine.medical_specialty, chemistry, business.industry, Extension study, medicine, In patient, Cushing's disease, medicine.disease, business, Pasireotide, Term (time)

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::badd8c06d559b9d2c6251cc561b5c741
    https://doi.org/10.1530/endoabs.56.gp204

    أضف إلى المفضلة
  5. 5
    Predictors of response to long-acting pasireotide in patients with Cushing's disease during a Phase III study

    المؤلفون: Libuse Tauchmanovà, Beverly M. K. Biller, Przemysław Witek, André Lacroix, S. Petersenn, Eliza B Geer, Michael Roughton, Yiming Li, Shoba Ravichandran, Richard A Feelders, Thierry Brue

    المصدر: Endocrine Abstracts.

    مصطلحات موضوعية: Oncology, chemistry.chemical_compound, medicine.medical_specialty, Long acting, chemistry, business.industry, Internal medicine, medicine, In patient, Cushing's disease, business, medicine.disease, Pasireotide

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b999ee42dd3380a3c9b99f99ce04e6fe
    https://doi.org/10.1530/endoabs.56.gp205

    أضف إلى المفضلة
  6. 6
    Monthly pasireotide provides clinical benefit over 12 months in patients with Cushing's disease

    المؤلفون: Rosario Pivonello, Nori Suzaki, Libuse Tauchmanovà, Ariel L. Barkan, Tuncay Delibasi, Pritam Gupta, Jochen Schopohl, André Lacroix, Stefan Petersenn, Marcello D. Bronstein

    المصدر: Endocrine Abstracts.

    مصطلحات موضوعية: medicine.medical_specialty, chemistry.chemical_compound, Pediatrics, chemistry, business.industry, Physical therapy, medicine, In patient, Cushing's disease, business, medicine.disease, Pasireotide

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::293f075c82713bc7adb208007c76e69e
    https://doi.org/10.1530/endoabs.49.ep1039

    أضف إلى المفضلة
  7. 7
    Octreotide subcutaneous (s.c.) depot, a novel ready-to-use formulation, provides higher exposure and maintains response in patients with acromegaly and functioning neuroendocrine tumours (NETs) previously treated with long-acting octreotide: Results from a phase 2, open-label, multicentre, randomized study

    المؤلفون: Marianne Pavel, Diego Ferone, Libuse Tauchmanovà, Fredrik Tiberg, Dieter Hörsch, Harald Lahner, Françoise Borson-Chazot, Håkan Olsson, Christelle Darstein, Rosario Pivonello, Anne Cailleux

    المصدر: Endocrine Abstracts.

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Depot, Urology, Octreotide, medicine.disease, Surgery, law.invention, Randomized controlled trial, law, Acromegaly, medicine, Ready to use, In patient, Open label, Previously treated, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::737df56cd615c484274e72b8b175b8cc
    https://doi.org/10.1530/endoabs.49.gp177

    أضف إلى المفضلة
  8. 8
    Idiopathic chronic urticaria and thyroid autoimmunity

    المؤلفون: Annamaria Colao, Libuse Tauchmanovà, Paola Colasanti, Alfonso Zuccoli, Vincenzo Nuzzo

    المصدر: Dermato-Endocrinology. 3:255-258

    مصطلحات موضوعية: endocrine system, medicine.medical_specialty, education.field_of_study, endocrine system diseases, business.industry, Endocrinology, Diabetes and Metabolism, Population, Thyroid, Dermatology, Single Center, medicine.disease, Gastroenterology, Iodine deficiency, Thyroiditis, Anti-thyroid autoantibodies, Endocrinology, medicine.anatomical_structure, Internal medicine, Cohort, medicine, Thyroid function, business, education, Research Paper

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5552fab0b92c8b02deac12ad2df0b8
    https://doi.org/10.4161/derm.3.4.17066

    PDF full text from Publisher Find this article in full text from ProQuest
    أضف إلى المفضلة
  9. 9
    Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients

    المؤلفون: Annamaria Colao, Libuse Tauchmanovà, Gaetano De Rosa, Gelsomina Mansueto, Antongiulio Faggiano, Marialaura Del Basso De Caro, Valeria Ramundo, Gaetano Lombardi, Lidice Brandao Tavares, Francesco Milone

    المساهمون: Faggiano, Antongiulio, L. B., Tavare, L., Tauchmanovà, Milone, Francesco, G., Mansueto, V., Ramundo, DEL BASSO DE CARO, Marialaura, G., Lombardi, DE ROSA, Gaetano, Colao, Annamaria

    المصدر: Clinical Endocrinology. 69:756-762

    مصطلحات موضوعية: Adult, Male, Parathyroidectomy, endocrine system, medicine.medical_specialty, Hypercalcaemia, Antineoplastic Agents, Hormonal, endocrine system diseases, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Octreotide, Antineoplastic Agents, Drug Administration Schedule, Young Adult, Endocrinology, Duodenal Neoplasms, Internal medicine, Multiple Endocrine Neoplasia Type 1, medicine, Humans, multiple endocrine neoplasia, Hypercalciuria, Aged, Hyperparathyroidism, Hormonal, business.industry, Somatostatin receptor, Delayed-Action Preparations, Female, Hyperparathyroidism, Primary, Middle Aged, Neuroendocrine Tumors, Pancreatic Neoplasms, Somatostatin, medicine.disease, MEN1, business, Primary, hormones, hormone substitutes, and hormone antagonists, Primary hyperparathyroidism, medicine.drug

    وصف الملف: STAMPA

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b7529ccb7ca2024e813b4a9c5e899e
    https://doi.org/10.1111/j.1365-2265.2008.03301.x

    View record at Wiley
    أضف إلى المفضلة
  10. 10
    Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women

    المؤلفون: Annalidia Sammartino, Annamaria Colao, Costantino Di Carlo, Giuseppe Bifulco, Giovanni A. Tommaselli, Libuse Tauchmanovà, Virginia Gargano, Carmine Nappi

    المساهمون: DI CARLO, Costantino, Tommaselli, GIOVANNI ANTONIO, Gargano, Virginia, Sammartino, Annalidia, Bifulco, Giuseppe, Tauchmanova, L., Colao, Annamaria, Nappi, Carmine

    المصدر: Menopause. 14:38-44

    مصطلحات موضوعية: Nomegestrol, medicine.medical_specialty, Peptide Hormones, osteocalcin, Administration, Cutaneous, leptin, Bone remodeling, Finger Phalanges, chemistry.chemical_compound, Osteoprotegerin, Bone Density, Internal medicine, medicine, Humans, Ultrasonography, biology, business.industry, Leptin, Estrogen Replacement Therapy, RANK Ligand, RANKL, Obstetrics and Gynecology, Estrogens, Middle Aged, medicine.disease, Menopause, postmenopause, Cross-Sectional Studies, Endocrinology, chemistry, osteoprotegerin, ghrelin, Osteocalcin, biology.protein, Osteoporosis, Receptors, Leptin, Female, estrogen-progestin therapy, Ghrelin, Progestins, business, hormones, hormone substitutes, and hormone antagonists, Blood sampling

    وصف الملف: STAMPA

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4776d0e3dc904789ae9c25178afccd82
    https://doi.org/10.1097/01.gme.0000227855.04732.7b

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء